Biocon Of India To Launch Two New Pre-Filled Syringes
This article was originally published in PharmAsia News
India's Biocon says it is ready to launch a new pre-filled syringe device for delivering two of the biotech's kidney and cancer drugs. The syringes are called Erypro Safe for the kidney drug and Nufil Safe for the cancer drug, both launched with California-based Safety Syringes. Both syringes are designed to reduce the amount of pain accompanying an injection, Biocon said. The firm said it plans to set an affordable price on the syringes in India, where pre-filled versions have been rare. (Click here for more
You may also be interested in...
Mexico's Genomma Lab recorded strong double-digit growth for its OTC business in the second quarter as sales more than doubled at its US consumer health operation.
New board directors named at Autolus Therapeutics, Beximco Pharmaceuticals, Tetraphase Pharmaceuticals and Vesigen.
After launching a biosimilar to Avastin (bevacizumab) in India, Cadila Pharma has now also launched rituximab and teriparatide biosimilars in its domestic market.